UBS Group’s Edoc Acquisition Corp. Warrant ADOCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-100
Closed -$3 10257
2023
Q3
$3 Sell
100
-65
-39% -$1 ﹤0.01% 9333
2023
Q2
$2 Buy
+165
New +$3 ﹤0.01% 8796
2022
Q4
Sell
-166
Closed 11361
2022
Q3
$0 Sell
166
-10,978
-99% -$369 ﹤0.01% 11226
2022
Q2
$0 Sell
11,144
-45
-0.4% -$2 ﹤0.01% 11229
2022
Q1
$1K Sell
11,189
-3,072
-22% -$408 ﹤0.01% 9994
2021
Q4
$3K Sell
14,261
-2,046
-13% -$516 ﹤0.01% 9720
2021
Q3
$4K Sell
16,307
-2,940
-15% -$860 ﹤0.01% 8711
2021
Q2
$7K Buy
19,247
+16,925
+729% +$5.21K ﹤0.01% 8371
2021
Q1
$1K Buy
+2,322
New +$1.4K ﹤0.01% 8818

Other funds holding ADOCW

UBS Group's ADOCW Position: Q4 2023 in Review

UBS Group sold out of Edoc Acquisition Corp. Warrant (ADOCW) in Q4 2023, closing a stake of 100 shares — an estimated $3 sold.

UBS Group first reported a position in ADOCW in Q1 2021 and held it in 9 quarters. The position peaked at $7K in Q2 2021. 18 funds tracked by Wall St. Rank hold ADOCW as of Q4 2023.

  • UBS Group reported no remaining Edoc Acquisition Corp. Warrant position as of Q4 2023 after selling out during the quarter.
  • UBS Group sold 100 Edoc Acquisition Corp. Warrant shares in Q4 2023, an estimated $3.
  • UBS Group first reported a position in Edoc Acquisition Corp. Warrant in Q1 2021 and held it in 9 quarters.
  • UBS Group's Edoc Acquisition Corp. Warrant position peaked at $7K in Q2 2021.
  • 18 funds tracked by Wall St. Rank held Edoc Acquisition Corp. Warrant as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.